Low-dose UVB irradiation prevents MMP2-induced skin hyperplasia by inhibiting inflammation and ROS

Dang,Lin; Wang,Yan; Xue,Yadong; He,Lei; Li,Yuzhen; Xiong,Jikui

doi:10.3892/or.2015.4072

Low-dose UVB irradiation prevents MMP2-induced skin hyperplasia by inhibiting inflammation and ROS

Authors:
- Lin Dang
- Yan Wang
- Yadong Xue
- Lei He
- Yuzhen Li
- Jikui Xiong
View Affiliations

Affiliations: Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China, Department of Pathology, Heilongjiang Provincial Hospital, Harbin, Heilongjiang 150036, P.R. China, Department of Dermatology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
Published online on: June 24, 2015 https://doi.org/10.3892/or.2015.4072
Pages: 1478-1486

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Skin cancer is one of the most common types of malignancy in the world. UV radiation is known as the primary environmental carcinogen responsible for skin cancer development. However, UV radiation is a ubiquitous substance existing in the environment and the physiological effect of UV radiation is consistently ignored. Therefore, in the present study, the physiological effect of UV radiation on inhibition of skin cancer was investigated. Normal mouse skin was processing by no pre-radiation or pre-radiation of low-dose UV before a medium or high dose of UV radiation. We found that the low-dose pre-radiated mouse skin tissue exhibited low skin inflammation, skin ROS production and consequently low skin epithelial hyperplasia after the medium-dose UV radiation compared with the no pre-radiated mouse. However, this inhibition was not indicated in the high-dose UV radiation group after low-dose pre-radiation. Furthermore, western blot analysis and gelatin zymography showed low expression and activation of MMP2 in the skin tissues processed following medium-dose radiation, but not in tissues treated with high-dose radiation after a low-dose pre-radiation. Further investigation of MMP2 inhibitors of TIMP2/TIMP4 showed an upregulated TIMP2 expression, but not TIMP4. Collectively, these data indicate that low-dose pre-radiation attenuates the skin inflammation and ROS production induced by medium-dose UV radiation and also elevates TIMP2 to withstand MMP2, therefore suppressing skin hyperplasia. The present study indicates a novel concept or prophylactic function of moderate UV radiation as a preventative strategy.

View Figures

View References

1	Jerant AF, Johnson JT, Sheridan CD and Caffrey TJ: Early detection and treatment of skin cancer. Am Fam Physician. 62:357–368. 375–356. 381–352. 2000.PubMed/NCBI
2	Marks R: An overview of skin cancers: Incidence and causation. Cancer. 75:607–612. 1995. View Article : Google Scholar : PubMed/NCBI
3	de Gruijl FD: Skin cancer and solar UV radiation. Eur J Cancer. 35:2003–2009. 1999. View Article : Google Scholar
4	Yoshikawa T, Rae V, Bruins-Slot W, Van den Berg JW, Taylor JR and Streilein JW: Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol. 95:530–536. 1990. View Article : Google Scholar : PubMed/NCBI
5	de Gruijl FR, van Kranen HJ and Mullenders LH: UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B. 63:19–27. 2001. View Article : Google Scholar : PubMed/NCBI
6	Melnikova VO and Ananthaswamy HN: Cellular and molecular events leading to the development of skin cancer. Mutat Res. 571:91–106. 2005. View Article : Google Scholar : PubMed/NCBI
7	Clydesdale GJ, Dandie GW and Muller HK: Ultraviolet light induced injury: Immunological and inflammatory effects. Immunol Cell Biol. 79:547–568. 2001. View Article : Google Scholar
8	Terui T, Okuyama R and Tagami H: Molecular events occurring behind ultraviolet-induced skin inflammation. Curr Opin Allergy Clin Immunol. 1:461–467. 2001. View Article : Google Scholar
9	Mantovani A, Alleven P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar : PubMed/NCBI
10	Diakos CI, Charles KA, McMillan DC and Clarke SJ: Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 15:e493–e503. 2014. View Article : Google Scholar : PubMed/NCBI
11	Bickers DR and Athar M: Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol. 126:2565–2575. 2006. View Article : Google Scholar : PubMed/NCBI
12	Caricchio R, McPhie L and Cohen PL: Ultraviolet B radiation-induced cell death: Critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J Immunol. 171:5778–5786. 2003. View Article : Google Scholar : PubMed/NCBI
13	Lawrence T, Willoughby DA and Gilroy DW: Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol. 2:787–795. 2002. View Article : Google Scholar : PubMed/NCBI
14	Holick MF: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 79:362–371. 2004.PubMed/NCBI
15	Holick MF: The vitamin D epidemic and its health consequences. J Nutr. 135:2739S–2748S. 2005.PubMed/NCBI
16	Bikle DD: The vitamin D receptor: A tumor suppressor in skin. Adv Exp Med Biol. 810:282–302. 2014.PubMed/NCBI
17	Gloster HM J and Neal K: Skin cancer in skin of color. J Am Acad Dermatol. 55:741–760. 2006. View Article : Google Scholar : PubMed/NCBI
18	Halder RM and Bang KM: Skin cancer in Blacks in the United States. Dermatol Clin. 6:397–405. 1988.PubMed/NCBI
19	Koh D, Wang H, Lee J, Chia KS, Lee HP and Goh CL: Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: Analysis of the Singapore Cancer Registry Data 1968–1997. Br J Dermatol. 148:1161–1166. 2003. View Article : Google Scholar : PubMed/NCBI
20	Vermeer M, Schmieder GJ, Yoshikawa T, van den Berg JW, Metzman MS, Taylor JR and Streilein JW: Effects of ultraviolet B light on cutaneous immune responses of humans with deeply pigmented skin. J Invest Dermatol. 97:729–734. 1991. View Article : Google Scholar : PubMed/NCBI
21	Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, McLean DI and Threlfall WJ: Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I Basal cell carcinoma Arch Dermatol. 131:157–163. 1995.
22	Rees JL: Genetics of hair and skin color. Annu Rev Genet. 37:67–90. 2003. View Article : Google Scholar : PubMed/NCBI
23	Jablonski NG: The evolution of human skin and skin color. Annu Rev Anthropol. 33:585–623. 2004. View Article : Google Scholar
24	Rastogi RP, Singh SP, Häder DP and Sinha RP: Detection of reactive oxygen species (ROS) by the oxidant-sensing probe 2′,7′-dichlorodihydrofluorescein diacetate in the cyanobacterium Anabaena variabilis PCC 7937. Biochem Biophys Res Commun. 397:603–607. 2010. View Article : Google Scholar : PubMed/NCBI
25	Luo JD, Wang YY, Fu WL, Wu J and Chen AF: Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice. Circulation. 110:2484–2493. 2004. View Article : Google Scholar : PubMed/NCBI
26	Braga PC, Marabini L, Wang YY, Lattuada N, Calò R, Bertelli A, Falchi M, Dal Sasso M and Bianchi T: Characterisation of the antioxidant effects of Aesculus hippocastanum L. bark extract on the basis of radical scavenging activity, the chemiluminescence of human neutrophil bursts and lipoperoxidation assay. Eur Rev Med Pharmacol Sci. 16(Suppl 3): 1–9. 2012.PubMed/NCBI
27	Mueller MM: Inflammation in epithelial skin tumours: Old stories and new ideas. Eur J Cancer. 42:735–744. 2006. View Article : Google Scholar : PubMed/NCBI
28	Graesslin O, Cortez A, Fauvet R, Lorenzato M, Birembaut P and Daraï E: Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: A clinical-pathological correlation study. Ann Oncol. 17:637–645. 2006. View Article : Google Scholar : PubMed/NCBI
29	Acker T, Fandrey J and Acker H: The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases. Cardiovasc Res. 71:195–207. 2006. View Article : Google Scholar : PubMed/NCBI
30	Kawagishi H and Finkel T: Unraveling the truth about antioxidants: ROS and disease: finding the right balance. Nat Med. 20:711–713. 2014. View Article : Google Scholar : PubMed/NCBI
31	Perera RM and Bardeesy N: Cancer: When antioxidants are bad. Nature. 475:43–44. 2011. View Article : Google Scholar : PubMed/NCBI
32	Ristow M and Zarse K: How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Exp Gerontol. 45:410–418. 2010. View Article : Google Scholar : PubMed/NCBI
33	Ristow M: Unraveling the truth about antioxidants: Mitohormesis explains ROS-induced health benefits. Nat Med. 20:709–711. 2014. View Article : Google Scholar : PubMed/NCBI
34	Tapia PC: Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients: 'Mitohormesis' for health and vitality. Med Hypotheses. 66:832–843. 2006. View Article : Google Scholar
35	Klabunde RE and Anderson DE: Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvas-cular leakage. J Vasc Res. 39:238–245. 2002. View Article : Google Scholar : PubMed/NCBI
36	Wullaert A, Bonnet MC and Pasparakis M: NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res. 21:146–158. 2011. View Article : Google Scholar
37	Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002. View Article : Google Scholar : PubMed/NCBI
38	Benson JM, Seagrave J, Weber WM, Santistevan CD, Grotendorst GR, Schultz GS and March TH: Time course of lesion development in the hairless guinea-pig model of sulfur mustard-induced dermal injury. Wound Repair Regen. 19:348–357. 2011. View Article : Google Scholar : PubMed/NCBI
39	Teulière J, Faraldo MM, Deugnier MA, Shtutman M, Ben-Ze'ev A, Thiery JP and Glukhova MA: Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development. 132:267–277. 2005. View Article : Google Scholar
40	Coussens LM, Tinkle CL, Hanahan D and Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 103:481–490. 2000. View Article : Google Scholar : PubMed/NCBI
41	Kuivanen TT, Jeskanen L, Kyllönen L, Impola U and Saarialho-Kere UK: Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas. Mod Pathol. 19:1203–1212. 2006. View Article : Google Scholar : PubMed/NCBI
42	Toth M, Bernardo MM, Gervasi DC, Soloway PD, Wang Z, Bigg HF, Overall CM, DeClerck YA, Tschesche H and Cher ML: Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. J Biol Chem. 275:41415–41423. 2000. View Article : Google Scholar : PubMed/NCBI
43	Hashimoto G, Aoki T, Nakamura H, Tanzawa K and Okada Y: Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett. 494:192–195. 2001. View Article : Google Scholar : PubMed/NCBI
44	Kai HS, Butler GS, Morrison CJ, King AE, Pelman GR and Overall CM: Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain. J Biol Chem. 277:48696–48707. 2002. View Article : Google Scholar : PubMed/NCBI